FIBA 2013 FIBA vs Sean McDonough Daniel

The International Basketball Federation (FIBA) has reported an anti-doping rule violation against the Player after his sample tested positive for the prohibited substance methylphenidate.
The FIBA notified the Player and ordered a provisional suspension.
The Player filed a statement in his defence and – after several postponements – he was heard for the FIBA Disciplinary Panel.
The Player stated he suffers from ADD (Attention Deficit Disorder) since the age of 12 and uses the prescribed medication Ritalin as law student in exam periods. He did not know the medication contained a prohibited substance and had no intention to enhance his performance.
The Panel finds the Player acted negligently in his responsibility that no prohibited substance enters his body. He did not research the ingredients of the medication in detail before using it and did not consult a doctor or sport physician about the use of medication prior to competitions.
Considering Player’s statement and the circumstances in this case the FIBA Disciplinary Panel decides to impose a 6 month period of ineligibility on the Player starting on the date of the provisional suspension, i.e. 21 January 2013.